New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma.

Despite continued advances, survival among patients with Hodgkin lymphoma differs by age, race and ethnicity, socioeconomic status, insurance, and treatment location. Inequities are evident across the cancer care continuum, from timely diagnosis and treatment initiation and clinical trial access, to posttreatment survivorship care. As the therapeutic landscape for Hodgkin lymphoma evolves, studies examining the impact of new treatments on disparities are needed to ensure that treatment advances benefit all populations equitably.